期刊文献+

内皮素受体阻断剂抑制磷酸甘油诱导血管平滑肌细胞钙化

Endothelin receptor antagonist BQ123 inhibits calcification in vascular smooth muscle cells induced by β-glycerophosphate
下载PDF
导出
摘要 目的:在离体钙化的血管平滑肌细胞上,观察内皮素受体阻断剂对血管平滑肌细胞(VSMCs)钙化的影响,探讨内皮素(ET)促进细胞钙化的信号转导和分子机制。方法:β-磷酸甘油制备钙化VSMCs;通过细胞钙含量,[45Ca2+]摄取,碱性磷酸酶活性测定,判断钙化程度,[3H]-胸腺嘧啶([3H]-TdR)和[3H]-亮氨酸([3H]-Leu)掺入测定细胞DNA合成,竞争性定量RT-PCR测定VSMCs骨桥蛋白(OPN)mRNA水平,放射免疫法测定培养上清ET含量。结果:与正常对照VSMCs相比,钙化VSMCs内钙含量,[45Ca2+]摄入及碱性磷酸酶活性分别增加119%、174%和7倍(P<0.01),OPN表达增加86%;细胞生长活跃,[3H]-TdR和[3H]-Leu分别增加71%和35%;钙化细胞培养基中内皮素含量较对照组增加35%(P<0.05)。而钙化加内皮素受体阻断剂BQ123组明显减轻VSMCs钙化程度,钙含量,[45Ca2+]摄入及碱性磷酸酶活性分别较钙化组降低33%、37%、40%(均P<0.01),OPN表达明显下调25%;细胞增殖活性明显降低。结论:BQ123可减轻VSMCs钙化程度,表明ET促进VSMCs钙化主要是通过内皮素A型受体(ET-A)途经。 AIM: To observe the effect of endothelin receptor antagonist (BQ123) on calcification in rat vascular smooth muscle cells (VSMCs) in vitro. METHODS: Calcification of cultured rat VSMCs was produced by incubation with β - glycerophosphate. Calcium content, Ca^2+ deposition and alkaline phosphatase activity were analyzed to estimate the extent of calcification. The DNA synthesis was detected by [^3H ] - TdR and [^3H ] - Leu incorporation. Osteopontin (OPN) mRNA was measured by competitive quantitative RT -PCR. Content of ET was measured by radioimmunoassay (RIA). RESULTS: The results showed that compared with the control, the content of calcium, [^45 Ca^2+ ] uptake and alkaline phosphatases activities in calcified VSMCs increased by 118% , 174% and 7 - fold ( all P 〈 0. 01 ) , respectively. The expression of OPN mRNA in calcified VSMCs was up - regulated by 86% ( P 〈 0.01 ). The calcified VSMCs grew rapidly, in which [^3H] - TdR and [^3H] - Leu were elevated by 71% and 35%. The content of ET in calcified VSMCs medium was increased by 35% as compared with control. Furthermore, calcified VSMCs plus BQ123 groups obviously relieved degree of calcification, of which calcium content, Ca^2+ deposition and alkaline phosphatase activities were 33% , 37% , 40% lower than those in calcified VSMCs ( P 〈 0. 01 ) , respectively. The expression of OPN mRNA was downregulated by 25% (P 〈 0. 01 ) and significantly inhibited VSMCs proliferation. CONCLUSION: BQ123 reduces VSMCs calcification, suggesting that ET promotes calcification in VSMCs mainly by ET/ ETA receptor pathway.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2008年第9期1690-1693,共4页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.30470693) 湖北省教育厅重点项目(No.2004D008) 郧阳医学院基础医学院中青年科技创新团队(No.2005CXZ02)
关键词 血管平滑肌细胞 内皮缩血管肽类 钙化 骨桥蛋白 Vascular smooth muscle cells Endothelins Calcification Osteopontin
  • 相关文献

参考文献15

二级参考文献53

  • 1张宝红,姜智胜,齐永芬,庞永正,唐朝枢,杜军保.肾上腺髓质素对大鼠血管钙化的影响[J].中华老年多器官疾病杂志,2002,1(2):117-121. 被引量:7
  • 2吴胜英,潘春水,刘秀华,蒋维,齐永芬,唐朝枢,李菊香.内源性血管紧张素Ⅱ对大鼠血管钙化的作用[J].中国病理生理杂志,2004,20(11):1961-1965. 被引量:14
  • 3[1]Riecher H,Albrecht HP,Amberg W,et al.Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists[J].J Med Chem,1996,39∶2123-2128.
  • 4[2]Nabi A,David K,Hsiao-Ling W,et al.Molecular characterization and regulation of the human endothelin receptors[J].J Pharmacol Exp Ther,1994,271∶762-768.
  • 5[3]Erry O,Anderew A,Samuel C,et al.Pharmacological characterization of A-127722:an orally active and highly potent ETA-selective receptor antagonist[J].J Pharmacol Exp Ther,1996,276∶473-481.
  • 6[4]Willian DL,Jr Murphy KL,Nolan NA,et al.Pharmacology of L-754142, a highly potent,orally active nonpeptidic endothelin antagonist[J].J Pharmacol Exp Ther,1995,275∶1518-1526.
  • 7[5]Ohlstein EH,Nambi P,Lago A,et al.Nonpeptide endothelin receptor antagonists:pharmacological characterization of SB-217242,a potent and highly bioavailable endothelin receptor antagonist[J].J Pharmacol Exp Ther,1996,276∶609-615.
  • 8[6]Winn M,Von TW,Opgenorth TT,et al.2,4-diaylpyrrolidine-3-carboxylic acids-potent ETA selective endothelin receptor antagonists discovery of A-127722[J].J Med Chem,1996,39∶1039-1048.
  • 9[7]Wu C,Chan MF,Stavors F,et al.Discovery of TBC 11251,a potent long acting orally active endothelin receptor—a selective antagonist[J].J Med Chem,1997,40∶1680-1687.
  • 10[8]Givert MM,Colucci WS,Gottlieb SS,et al.Acute ETA receptor blockade reduce pulmonary vascular resistance in patients with chronic heart failure[J].Circulation,1998,98(17s)∶3044-3051.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部